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OBJECTIVES: The aim of this report is to investigate Mycobacterium abscessus infections at a rural clinic and 
carry out a surveillance program to determine the extent and source of these infections. 
METHODS: The authors conducted an active surveillance investigation of 36 patients who had visited the clin-
ic since 1 July 2008. Clinical specimens were collected from the patients and an envirnmental investigation. 
Pulsed-field gel elctrophoresis (PFGE) was performed for comparing with M. abscessus isolates from the pa-
tients.
RESULTS: Six specimens were obtained from the 6 patients respectively and 22 environmental samples were 
obtained. M. abscessus was isolated from the wounds of two patients, and various nosocomial pathogens, but 
not M. abscessus, were isolated from the surrounding environment. Two strains of M. abscessus from patients 
were identical as a result of PFGE. 
CONCLUSION: Infection control education including proper hand hygiene should be emphasized for physi-
cians performing invasive procedures. There also needs to be more attention for invasive procedures manage-
ment, including trigger point injection and epidural block in rural clinics.
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INTRODUCTION
Nontuberculous mycobacteria (NTM) are found in the natu-
ral environment throughout the world and include at least 65 
different species [1]. NTM exist widely in soil and water and 
are known to colonize and cause disease in a broad range of 
animal species. There is sufficient evidence that nosocomial trans-
mission of these organisms is increasing [2,3]. Mycobacterium 
abscessus is an acid-fast bacillus (AFB) classified as a pathogen-
ic “rapid growing” strain of NTM [2,4]. M. abscessus was first 
reported by Moore and Frerichs in 1953 [5]. Although M. ab-
scessus is an uncommon causative pathogen of human disease, 
it can cause skin and soft tissue infections (SSTI) on damaged 
skin lesions following inoculation, minor trauma or surgery [5,6].
Trigger point injection (TPI) is widely used for treatment by 
some physicians to reduce myofascial pain and headache that is 
unresponsive to medical treatments in Korea [7,8]. Trigger 
points may irritate the nerves around them and cause referred 
pain, or pain that is felt in another part of the body. Lidocaine 
or steroid mixed normal saline injection with a 24 or 26 gauge 
needle to the trigger point helps to reduce pain. Many surveys 
regarding the safety of this procedure have been conducted but 
the effectiveness of TPI is controversial for a decade [9]. 
There have been few reports of M. abscessus outbreak associ-
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ated with TPI [10-12] and/or epidural block (EB) procedures 
over the past years. The aim of this study was to investigate M. 
abscessus infections at a rural clinic and carry out a surveillance 
program to determine the extent and source of these infections. 
MATERIALS AND METHODS
Outbreak recognition
On 2 March 2009, a patient (index case) who was referred 
from a local clinic in Ha-dong-gun province, was diagnosed 
with an NTM infection in hospital A and was reported to the 
Korea Centers for Disease Control and Prevention (KCDC). He 
had multiple nodules and abscesses following EB procedure at 
a rural clinic in mid-October 2008. The lesions were initially 
treated with antibiotics, abscess incision and drainage, without 
improvement. 
On 9 March 2009, the team from KCDC, the public health 
center and the provincial government performed an epidemio-
logical investigation at the clinic in Ha-dong-gun province and 
interviewed the physician who performed the TPI and/or EB 
procedures. In the field, our team was notified that similar pa-
tients had been treated in another hospital B. These events 
prompted the initiation of an epidemiological study to investi-
gate the outbreak. 
From 1 July 2008 to 28 February 2009, 496 patients had vis-
ited the clinic in Ha-dong-gun province. We attempted to con-
tact all 496 patients; 428 by telephone and 68 by mail. Our 
team made contact with 426 patients and found 53 patients 
had symptoms of a skin and soft tissue infection. Of these 53 
patients, 36 (68.0%) agreed to participate in the present study. 
They were notified of a suspicious outbreak of M. abscessus in-
fection following TPI and/or EB procedures at the clinic and the 
danger of the infection and interviewed by telephone with a 
standardized questionnaire.
Case identification
Thirty-six patients agreed to participate in the present study 
were classified into two categories. A confirmed case was de-
fined as a SSTI diagnosed after 1 July 2008 and due to M. ab-
scessus infection following a TPI and/or an EB at the clinic. A 
probable case was defined as a SSTI, diagnosed after 1 July 
2008, following a TBI and/or an EB in the clinic that did not re-
spond to standard antibacterial therapy. 
Active surveillance of patients by medical record survey and 
telephone who had visited the clinic since 1 July 2008 was con-
ducted to define the extent of the outbreak. Board-certified 
physicians interviewed potential case patients using a standard-
ized questionnaire to obtain data on demographic characteris-
tics, pertinent details of the TPI and/or EB, additional proce-
dures afterwards, the date of symptom onset, symptoms and 
treatment. The study protocol was approved by the Institutional 
Review Board at KCDC.
Environmental investigation
On 9 March 2009, 22 environmental specimens were collect-
ed from the clinic for mycobacterial culture. Specimens were 
taken from all devices and materials within the clinic that could 
have come into contact with the patient’s skin before, during 
and after the TPI and/or EB procedure session, including pil-
lows, beds, blankets, humidifier, air conditioner, front desk, 
telephone and refrigerator. Water samples were taken from the 
sink, water bucket, bathroom, and faucets. The samples, includ-
ing disposable syringes, water for injection, drugs for injection 
may not accurately represent the environmental conditions at 
the time of infection.
Laboratory testing
Clinical specimens were obtained from 6 patients. In 2 pa-
tients, pus and exudates samples were collected from the in-
fected wounds of the thigh and waist by sterile swabs respec-
tively. In 2 patients, pus sample were collected from the infect-
ed wound of the waist and neck by needle-aspiration respec-
tively. In the remaining 2, in addition, excision skin biopsies 
were done from the thigh and chest. 
Specimens were prepared as described previously [13,14]. 
Species identification for these isolates was done by means of 
comparative sequence analyses of portions of the 16S rRNA 
gene, hsp65 and rpoB, which were amplified by polymerase 
chain reaction (PCR) [15,16].
Randomly amplified polymorphic DNA (RAPD) PCR, using 
three primers, INS-2, IS986-FP, URP-6, as described by Zhang 
et al. [17] with modification was performed on patient and en-
vironmental samples.
Samples then underwent pulsed-field gel electrophoresis (PF-
GE) analysis. The large restriction fragments were divided and 
digested with Asel, as previously described [18].
Isolates were tested for susceptibility against amikacin, cefox-
itin, ciprofloxacin, clarithromycin, doxycycline, imipenem, line-
zolid, tobramycin and moxifloxacin by means of a broth micro-
dilution method at the National Institute of Health [19].
TPI and EB procedure description 
Twenty-one patients (58.3%) were disinfected with 75% eth-
anol swabs before a TPI and 17 patients (47.2%) were disin-
fected again after the TPI with 75% ethanol swabs. Before an 
EB, the skin was swabbed with povidone iodine and was not 
re-swabbed after an EB. After the skin was swabbed with 75% 
ethanol, a TPI was performed using disposable needles without 
time to dry. Physician applied the antiseptic using concentric 3
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circles from the center toward the outside. He used a glove only 
his left hand without performing hand hygiene. Epidural needle 
and spinal set were recycled after sterilization by autoclave. 
Drugs used for the TPIs were lidocaine, normal saline and 
dexamethasone. Lidocaine and normal saline were used for the 
EBs. High-frequency therapy was administered after a TPI, but 
not after an EB. Hot pack s were not used with any patients. 
RESULTS
Case patients
The clinic was opened from 7 May 2005 to 1 March 2009. 
Most patients visited the clinic with neuromuscular pains. Of 
the 36 patients interviewed, Thirteen (36%) were male and 23 
(64%) were female. The median age was 56 years (range 34 to 
81 years). Underlying diseases were diabetes (n=4, 11.1%), 
hypertension (n=4, 11.1%), cerebral infarction (n=1, 2.8%) 
and malignant disease (n=1, 2.8%). 
Of the 36 patients, 29 (80.6%) underwent combined TPI and 
EB procedures at the clinic. Five (13.9%) underwent TPI only, 
while two (5.6%) underwent an unknown procedure. M. ab-
scessus was isolated from the wound swab and needle aspira-
tion of two patients respectively (5.6%). The average number 
of needle passages per day was as follows: 1 to 9 (27 patients, 
75.0%) and 10 and over (9 patients, 25.0%). Five patients 
(13.9%) were treated with high-frequency therapy after their 
TPI and EB procedures. 
Thirty-six patients who underwent TPIs and/or EBs between 1 
July 2008 and 28 February 2009 subsequently had skin lesions 
or abscesses at the injection sites. The outbreak ceased at the 
end of February 2009 due to the closure of the clinic (Figure 1).
Clinical characteristics
Ten patients (27.8%) had systemic symptoms, such as a fever 
or chills, and two patients (5.6%) had lymphadenopathy around 
their skin lesions. Out of 36 patients with papular skin lesions, 
23 complained of a burning sensation around the skin lesion 
and 35 had erythematous papular skin lesions. Thirty-six pa-
tients (100%) had skin lesions corresponding to the injection 
site. The lesion sites were located as follows: thigh (n=20, 
55.6%), waist (n=12, 33.3%), knee (n=12, 33.3%), shoulder 
(n=9, 25.0%), buttocks (n=7, 19.4%), hand (n=5, 13.9%), 
back (n=2, 5.6%), wrist (n=2, 5.6%) and neck (n=1, 2.8%). 
In addition, the mean number of lesions was 2.9 (range 0 to 
30). The mean incubation time was 5.5 days (range 1 to 15 days). 
Clinical characteristics are summarized in Table 1.
Environmental investigation
The environmental samples were obtained on 9 March 2009. 
The samples may not have accurately represented the environ-
mental conditions at the time of the outbreak because the clinic 
was closed due to private problems before the investigation. M. 
abscessus was not isolated from the 22 environmental samples 
taken from the clinic. However, most cultures were contaminat-
ed by various nosocomial pathogens, including several NTM 
Figure 1. Epidemic curve of Mycobacterium abscessus infections following trigger point injection and/or epidural block. The mean incuba-
tion time was 5.5 days (range 1 to 15 days).
TPI, trigger point injection,  EB, epidural block.
*Index case presented with a skin lesion about two weeks after having a TPI and an EB in mid-October 2008; 
†The local clinic was closed; 
‡First patient was 
reported; 
§A formal epidemiological study was initiated; 
IIThe physician at the clinic in Hadong-gun was interviewed. 22 environmental specimens were col-
lected from the clinic.
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species such as Mycobacterium septicum, M. avium and M. 
mageritense.
Microbiologic examination
Six specimens were obtained from the 6 patients respectively 
in four different hospitals (A, B, C and D). Mycobacteria were 
isolated from the wounds of two patients in two hospitals re-
spectively (B and C). For these isolates, nucleotide sequences of 
the portions of the 16S rRNA, hsp65 and rpoB were determined 
and analyzed to identify the isolates as M. abscessus (Data not 
shown). Two isolates were identified as M. abscessus, with the 
same sequence analysis. Two isolates also were determined by 
RAPD-PCR and the isolates were identified as M. abscessus 
(Figure 2A). 
One was a patient’s specimen which was collected from the 
wound swab in hospital B on 9 March 2009. The other speci-
men was collected from the wound needle aspiration in anoth-
er hospital C. M. abscessus isolates from the two patients’ skin 
wounds were compared using RAPD-PCR and PFGE analysis. 
RAPD-PCR and PFGE analysis resulted in an identical pattern 
among two M. abscessus strains (Figure 2B), implying that a 
single strain of M. abscessus was involved in the outbreak. The 
other four specimens were not identified a M. abscessus.
Both of the isolates showed identical antimicrobial suscepti-
bility profiles. They were sensitive to amikacin and clarithromy-
cin, but resistant to doxycycline and ciprofloxacin. 
Treatment and outcomes
Thirty-three (91.7%) of 36 patients were admitted to the dif-
ferent hospitals. Among them, 13 patients (39.4%) had under-
Table 1. Clinical characteristics of patients with Mycobacterium ab-
scessus infections following trigger point injection and/or epidural 
block
Characteristics Total
patients
Confirmed 
cases
Probable 
cases
No. 36 2 34
Average no. of needle passages per day
  1-9 27 (75) 2 (100) 25 (73.5)
  ≥10 9 (25) 0 (0) 9 (26.5)
Local symptoms
  Erythematous nodule or mass 35 (97.2) 1 (50) 34 (100)
  Abscess 27 (75) 1 (50) 26 (76.5)
  Pain 23 (63.9) 0 (0) 23 (67.6)
  Redness or swelling 18 (50) 0 (0) 18 (52.9)
  Itching 15 (41.7) 0 (0) 15 (44.1)
  Enlargement of draining lymph node 2 (5.6) 0 (0) 2 (5.9)
Systemic symptoms* 10 (27.8) 1 (50) 9 (26.5)
Disinfection with ethanol swab
  Before TPI 21 (58.3) 2 (100) 19 (55.9)
  After TPI 17 (47.2) 1 (50) 16 (47.1)
Additional procedure after TPI/EB
  High-frequency therapy 5 (13.9) 2 (100) 3 (8.8)
  Taking bath on the day after TPI/EB, no (%) 4 (11.1) 0 (0) 4 (11.8)
Values are presented as number (%).
TPI, trigger point injection; EB, epidural block.
*Systemic symptoms include febrile sense, chill, and fatigue.
Figure 2. Molecular strain typing of isolates by randomly amplified polymorphic DNA PCR (RAPD-PCR) (A) and pulsed-field gel electropho-
resis (PFGE) (B). 
(A) DNA fragments amplified by RAPD-PCR using three primers, INS-2, IS986-FP, URP-6. Lane M, 1Kb marker (Solgent); Lane 1, patient isolate in hospital B; 
Lanes 2, patient isolate in hospital C; Lanes 3, M. abscessus ATCC19977 (Type strain of Mycobacterium abscessus) control. (B) PFGE patterns of genomic 
DNA digested with Asel. Lane M, Lambda ladder PFG marker (NEB); Lane 1, patient isolate in hospital B; Lane 2, patient isolate in hospital C. Both of the 
isolates from the two patients had identical patterns.
PCR, polymerase chain reaction.
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gone incision and drainage and two patients (6.1%) underwent 
aspiration of the lesions. The other 18 patients (54.5%) were 
given only antibiotic therapy. Ten of 18 patients were treated 
administration of oral clarithromycin (500 mg, twice daily) for 
4-6 months and the other patients also received either amika-
cin or a combination of clarithromycin and ciprofloxacin. All 
admitted patients recovered fully during the investigation and 
no deaths occurred.
DISCUSSION
Outbreaks of mycobacteria have been reported following in-
jections of histamines, lidocaine, saline solution, vaccines, disin-
fectant solution and adrenal cortex extracts [10,20,21]. Injec-
tion safety is an enormous global health challenge both in the 
developing world, where safe injection practices are often lack-
ing, and in developed countries, where new technologies and 
the transition of clinical practice to less regulated outpatient 
settings is occurring [22-24]. With the increase of TPI and/or EB 
procedures, adverse events also have been reported, such as 
needle pain, tiredness, bleeding, headache, faintness, and rarely, 
pneumothorax [25,26].
Thirty-six patients who underwent TPIs and/or EBs at a same 
rural clinic between 1 July 2008 and 28 February 2009 subse-
quently had skin lesions or abscesses at the injection sites The 
symptoms seen in our cases is similar to that reported in previ-
ous outbreaks of M. abscessus infection following acupuncture 
in Korea [14,27]. Erythematous nodule or mass, a finding re-
portedly suggestive of M. abscessus infection following acu-
puncture [14], were seen in almost all of our patients. In our 
cases, M. abscessus was isolated from two patients only in two 
hospitals (B and C). Two strains of M. abscessus from patients 
were identical using PFGE analysis. Moreover, the 2 isolates 
were compared with use of RAPD-PCR with reference to type 
strain of M. abscessus (M. abscessus ATCC 19977) because al-
most 50% of strains cannot be assessed by PFGE [17]. Two 
methods resulted in an identical pattern among the 2 isolates. 
There were several limitations in identifying the exact con-
tamination source. Because the clinic was closed due to private 
problems before the completion of the investigation, the envi-
ronmental sources for the rapidly growing mycobacteria and 
their mechanism of distribution could not be elucidated. 
However, there are several possible sources of the outbreak. 
First, inadequate sterilization of the injection sites could be the 
source of the infection. Because 75% ethanol and povidone io-
dine have a wide-spectrum germicidal effect, they are common-
ly used as a disinfectant for procedures. When improperly used, 
however, the mixture is not as effective as a disinfectant. A con-
siderable amount of time is necessary for the prevention of my-
cobacterial infections after 75% ethanol or povidone iodine is 
applied [28]. Second, insufficient equipment sterilization and 
the clinic’s general environment could be the source of the in-
fection. The equipment, including epidural needle, spinal set 
were sterilized with an autoclave by a nurse who works in a 
clinic without precise protocol of sterilization. A third possibili-
ty is improper preparation of the injection drugs and septic 
techniques. Drugs used for the TPIs were lidocaine, normal sa-
line and dexamethasone, but dexamethasone was not used for 
the EBs. Since the middle of October 2008, the physician per-
formed the TPIs drugs, including lidocaine and normal saline, 
except dexamethasone. After finishing the treatment of the last 
patient each day, the physician prepared the following day’s in-
jection drugs and placed them in a refrigerator for up to two 
days. When the outbreak began, the physician had been pre-
paring the injection drugs and placing them in a refrigerator for 
up to two days. The drugs were not sterilized. The samples, in-
cluding disposable syringes, water for injection, drugs for injec-
tion may not accurately represent the environmental conditions 
at the time of infection because the clinic was closed due to pri-
vate problems before the completion of the investigation. Al-
though contaminated drugs were not determined as the source 
of the outbreak, the long-term storage of the injection drugs 
could be implicated. Additionally, whenever the physician per-
formed TPI and/or EB, he used a glove only his left hand with-
out performing hand hygiene; creating yet another potential 
source of infection. Moreover, the physician responsible for the 
injections used multiple-dose bottles (100 mL) of normal saline 
in order to dilute lidocaine and dexamethasone. Yuan et al. [11] 
reported cases of post-injection abscesses from extrinsic con-
tamination of multiple-dose bottles of normal saline.
Another limitation was the difficulty in conducting the epide-
miological study. Most of the 36 patients with symptoms had 
recovered before the study, so we obtained only six specimens 
in four hospitals (A, B, C and D). Thirty-three (91.7%) of 36 
patients were treated in different hospitals, which limited our 
ability to obtain treatment methodology and results. We did not 
investigate whether the outbreak had started prior to 1 July 
2008, because the physician did not report any patients with 
adverse effects before then. We could not compare patients 
with controls due to lack of consent and participation in this 
present study.
In conclusion, we report an outbreak of M. abscessus infec-
tion following TPI and/or EB that involved 36 patients. There 
needs to be more attention for invasive procedures manage-
ment, including TPI and EB in rural clinics. Epidemiologic stud-
ies also are needed to explain the exact source of infection to 
prevent future outbreaks of M. abscessus infection.6
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